SGSC lock-in agreement9 Sep 2021 15:43
SGSC holds 1,100,000,000 ordinary shares in Vela, representing 7.13 per cent. of Vela's issued share capital. SGSC's ordinary shares are subject to a lock-in agreement until the successful completion of Phase II of the ARCADIA trial, or for a period of two months following completion of the ARCADIA trial, should the outcome of the trials not meet the minimum threshold. Following the minimum threshold of primary/secondary and safety endpoint conditions being met, of the ARCADIA Phase II clinical trial, the lock-in period for SGSC's shareholding will end on 10 September 2021. Just wondering if someone could explain what happens on the 10th